|
|
Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries
Antoine Faucon
Pierrefonds, QC H9K 1L2
Canada
Phone: 1 514 779 9623 Fax: 1 514 626 0956
E-Mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Description:
Jiagen Biotechnologies is a research-based company that supplies a broad range of quality peptides, proteins, enzymes, carbohydrates, lipids and antibodies for life sciences researchers and pharmaceutical industries. Products: Our featured products include Aprotinin, Beta Glucanase, Bilirubin, Bromelain, Chitosan, Chondroitin Sulfate (Chondroitin Sulphate), Chymotrypsin, Chymosin (rennin), Coenzyme A, free acid (CoA), Coenzyme A Trilithium Salt (CoA-Li), Coenzyme Q10 (CoQ10), Cytochrome C, Dextran, DNase, Follicle Stimulating Hormone (FSH), Glucosamine Hydrochloride, Heparin Sodium and Low Molecular Weight Heparins (LMWH), Heparinoids, Human Chorionic Gonadotropin (HCG), Hyaluronic Acid (Sodium Hyaluronate), Hyaluronidase, Insulin, Kallikrein, L-Asparaginase, Lysozyme, Oat Beta Glucans, Yeast Beta Glucans, Pancreatic Elastase, Pancreatin, Papain, Pepsin, Porcine Gastric Mucin (PGM), Pregnant Mare Serum Gonadotropin (PMSG), Serums, Thrombin, Trypsin, Trypsin Inhibitor, Urokinase, GST (6F5) Tag Antibody, Beta-Actin Antibody, Alpha-Tubulin Antibody, Beta-Tubulin Antibody, GAPDH Antibody and more. Technologies and contract research services: We provide our clients with cost effective innovative technologies to meet their cGMP manufacturing requirements and to help them with technology transfer. We offer custom monoclonal and polyclonal antibody development, protein expression and purification as well as contract process development, scale-up and optimization services.
Selected Categories:
Last update of this entry: September 09, 2014
|